Biography
John Kilama
John Kilama, Ph.D., founder and president of GBDI, has a broad background in pharmaceuticals, biotechnology and agro-chemistry. Born in Uganda, Dr. Kilama received his B.S. in Chemistry from Berea College, Berea Kentucky in 1976, B.S. in Pharmacy from the University of Kentucky in 1979, and a Ph.D. in Medicinal Chemistry from the University of Arizona in 1988. Dr. Kilama was a postdoctoral fellow at the University of Minnesota where he provided key support to the synthetic development of Cabovir, an HIV reverse transcriptase nucleoside inhibitor. Dr. Kilama joined DuPont Company in 1989. At DuPont, Dr. Kilama was awarded several patents that cover innovative applications of new class of chemicals in the life sciences and published several scientific peer review articles in internationally recognized journals. Dr. Kilama has presented expert testimony twice to the U.S. House of Representatives’ committees on agriculture and science. His articles have appeared in leading publications in Bangladesh, Botswana, Brazil, China, India, Nigeria, South Africa, Switzerland, Tanzania, Thailand, Costa Rica, U.K. and the United States. Dr. Kilama has been an organizer of training courses and symposia for decision makers in areas of Intellectual Property and Healthcare Strategy. He has conducted several training courses in low to middle income countries on a wide range of topics including: Global Aspects of technology Transfer, Biotechnology; Biotechnology and Law.
Presentation(s) for John Kilama :
John Kilama, Ph.D., founder and president of GBDI, has a broad background in pharmaceuticals, biotechnology and agro-chemistry. Born in Uganda, Dr. Kilama received his B.S. in Chemistry from Berea College, Berea Kentucky in 1976, B.S. in Pharmacy from the University of Kentucky in 1979, and a Ph.D. in Medicinal Chemistry from the University of Arizona in 1988. Dr. Kilama was a postdoctoral fellow at the University of Minnesota where he provided key support to the synthetic development of Cabovir, an HIV reverse transcriptase nucleoside inhibitor. Dr. Kilama joined DuPont Company in 1989. At DuPont, Dr. Kilama was awarded several patents that cover innovative applications of new class of chemicals in the life sciences and published several scientific peer review articles in internationally recognized journals. Dr. Kilama has presented expert testimony twice to the U.S. House of Representatives’ committees on agriculture and science. His articles have appeared in leading publications in Bangladesh, Botswana, Brazil, China, India, Nigeria, South Africa, Switzerland, Tanzania, Thailand, Costa Rica, U.K. and the United States. Dr. Kilama has been an organizer of training courses and symposia for decision makers in areas of Intellectual Property and Healthcare Strategy. He has conducted several training courses in low to middle income countries on a wide range of topics including: Global Aspects of technology Transfer, Biotechnology; Biotechnology and Law.
Presentation(s) for John Kilama :